Radiotherapy in the treatment of pituitary adenomas
- PMID: 3403314
- DOI: 10.1016/s0360-3016(98)90009-8
Radiotherapy in the treatment of pituitary adenomas
Abstract
Between 1970 and 1985, 145 patients were treated for pituitary adenomas and 126 patients were available for analysis. Sixty patients were treated with surgery alone (Group I), 54 were treated with surgery and radiation therapy (Group II), and 12 received irradiation only without tissue diagnosis (Group III). Extent of tumor was evaluated by CT scan, PEG, and surgical reports. There were 22 microadenomas in Group I and only 1 microadenoma in Group II. The mean follow-up was 6.4 years, 85% (51/60) of patients in Group I, 93% of patients in Group II, and only 50% of those treated with irradiation alone achieved tumor control. With subsequent salvage treatment, overall tumor control in Group I was 97%. The mean time to recurrence was 3.7 years (Group I), 4.5 years (Group II), and 4 years (Group III). In summary, combined treatment is effective to decrease the chance of local recurrence of pituitary adenomas. Nevertheless, because of successful salvage treatment after surgical failure, overall outcome is similar. Without persistent symptom after surgery or large residual tumor in or near the critical structures, postoperative irradiation can be deferred until tumor regrowth.
Similar articles
-
Recurrent pituitary adenomas after surgical resection: the role of radiation therapy.Radiology. 1990 Oct;177(1):273-5. doi: 10.1148/radiology.177.1.2399329. Radiology. 1990. PMID: 2399329
-
Giant pituitary adenomas: role of radiotherapy.Int J Radiat Oncol Biol Phys. 1993 Mar 15;25(4):677-81. doi: 10.1016/0360-3016(93)90015-n. Int J Radiat Oncol Biol Phys. 1993. PMID: 8454486
-
Radiotherapy for pituitary adenoma: long-term outcome and sequelae.Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):437-44. doi: 10.1016/s0360-3016(97)00335-0. Int J Radiat Oncol Biol Phys. 1997. PMID: 9308948
-
Pituitary adenomas: results of 684 surgically treated patients and review of the literature.Surg Neurol. 2000 Mar;53(3):211-9. doi: 10.1016/s0090-3019(00)00171-3. Surg Neurol. 2000. PMID: 10773251 Review.
-
Diagnosis and treatment of pituitary adenomas.Minerva Endocrinol. 2004 Dec;29(4):241-75. Minerva Endocrinol. 2004. PMID: 15765032 Review.
Cited by
-
Telomerase activity in pituitary adenomas: significance of telomerase expression in predicting pituitary adenoma recurrence.J Neurooncol. 2003 Jun;63(2):155-62. doi: 10.1023/a:1023935621976. J Neurooncol. 2003. PMID: 12825819
-
Delayed radiation necrosis of the central nervous system in patients irradiated for pituitary tumours.J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):949-55. doi: 10.1136/jnnp.55.10.949. J Neurol Neurosurg Psychiatry. 1992. PMID: 1431959 Free PMC article.
-
Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts.Acta Neuropathol. 1992;84(2):178-83. doi: 10.1007/BF00311392. Acta Neuropathol. 1992. PMID: 1381860
-
Experience in management of 51 non-functioning pituitary adenomas: indications for post-operative radiotherapy.J Endocrinol Invest. 2005 Jan;28(1):18-22. doi: 10.1007/BF03345524. J Endocrinol Invest. 2005. PMID: 15816366
MeSH terms
LinkOut - more resources
Full Text Sources
Medical